Medical Cannabis Evidence-Based Care: Endocannabinoid System Clinical Research and Cannabinoid Clinical Trials
Clinical Takeaway People experiencing a first episode of psychosis have measurable rates of criminal legal involvement both before and after entering treatment, with specific individual factors predicting who is at greatest risk. Early identification of…
Cannabis use patterns in first episode psychosis and schizophrenia: A scoping review and case series.
Cannabis use is associated with psychosis development and symptom relapse in persons with schizophrenia spectrum disorders (SCZ). As U.S. states legalize can...
Endocannabinoid System & Psychosis Risk: Clinical Evidence
Clinical Takeaway People experiencing a first episode of psychosis have measurable rates of criminal legal involvement both before and after diagnosis, and certain clinical and demographic factors can help predict who is at greatest risk. Early,…
Cannabis use patterns in first episode psychosis and schizophrenia: A scoping review and case series.
Cannabis use is associated with psychosis development and symptom relapse in persons with schizophrenia spectrum disorders (SCZ). As U.S. states legalize can...